Angiogenesis- and hypoxia-associated proteins as early indicators of the outcome in patients with metastatic breast cancer given first-line bevacizumab-based therapy

Siu W. Lam, Nienke M. Nota, Agnes Jager, Monique M E M Bos, Joan Van Den Bosch, Ankie M T Van Der Velden, Johanneke E A Portielje, Aafke H. Honkoop, Harm Van Tinteren, Epie Boven*, S. M. De Groot, S. C. Linn, H. J. Braun, M. Los, J. R. Kroep, B. Tanis, C. H. Smorenburg, J. M Meerum Terwogt, J. M G H Van Riel, M. O. Den BoerJ. Douma, F. Jeurissen, J. Berends

*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

2 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Angiogenesis- and hypoxia-associated proteins as early indicators of the outcome in patients with metastatic breast cancer given first-line bevacizumab-based therapy'. Together they form a unique fingerprint.

Medicine & Life Sciences